(S (NP-SBJ-11 (ADJP (NN Kappa) (JJ B-specific)) (NN DNA) (NN binding) (NNS proteins)) (VP (VBP are) (ADVP (RB differentially)) (VP (VBN inhibited) (NP (-NONE- *-11)) (PP (IN by) (NP-LGS-COOD (NP (NN enhancer) (NNS mutations)) (CC and) (NP (JJ biological) (NN oxidation)))))) (. .))
(S (NP-SBJ-12 (NP (NP (NP (NN Kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN kappa) (NN B)) (-RRB- -RRB-))) (NN enhancer) (NN binding) (NNS proteins)) (VP (VBN isolated) (NP (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (VBN activated) (JJ human) (NN T) (NNS cells))))))) (VP (VBP produce) (NP (CD two) (JJ distinct) (NN nucleoprotein) (NNS complexes)) (SBAR-TMP (WHADVP-14 (WRB when)) (S (NP-SBJ-13 (-NONE- *-12)) (VP (VBN incubated) (NP (-NONE- *-13)) (PP (IN with) (NP (NP (DT the) (NN kappa) (NN B) (NN element)) (PP (IN from) (NP (DT the) (NP (NP (NN interleukin-2) (NN receptor-alpha)) (PRN (-LRB- -LRB-) (NP (NN IL-2R) (NN alpha)) (-RRB- -RRB-))) (NN gene))))) (ADVP (-NONE- *T*-14)))))) (. .))
(S (NP-SBJ-15 (DT These) (CD two) (JJ DNA-protein) (NNS complexes)) (VP (VBP are) (VP (VBN composed) (NP (-NONE- *-15)) (PP (IN of) (NP (NP (NP (QP (IN at) (JJS least) (CD four)) (NN host) (NNS proteins)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN p50)) (, ,) (NP (NN p55)) (, ,) (NP (NN p75)) (, ,) (NP (NN p85))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP-16 (NP (DT each)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ (-NONE- *T*-16)) (VP (VBZ shares) (NP (JJ structural) (NN similarity)) (PP (IN with) (NP (DT the) (NN v-rel) (NN oncogene) (NN product)))))))))) (. .))
(S (NP-SBJ-17 (NP (JJ Nuclear) (NN expression)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ is) (VP (VBN induced) (NP (-NONE- *-17)) (PP (IN with) (NP (ADJP (RB distinctly) (JJ biphasic)) (NNS kinetics))) (PP-TMP (VBG following) (NP (NN phorbol) (NN ester) (NN activation)) (PP (IN of) (NP (NP-100 (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN (p75 p55)) (JJ early) (NP (-NONE- *RNR*-100))) (CC and) (NP (NN (p85 p50)) (JJ late) (NP (-NONE- *RNR*-100)))) (-RRB- -RRB-))))))) (. .))
(S (NP-SBJ (JJ DNA-protein) (NN crosslinking) (NNS studies)) (VP (VBP have) (VP (VBN revealed) (SBAR (IN that) (S (NP-SBJ (DT the) (ADJP (ADVP-TMP (RBR more) (RB rapidly)) (VBG migrating)) (NN B2) (NN complex)) (VP (VBZ contains) (NP-COOD (CC both) (NP (NN p50)) (CC and) (NP (NN p55))) (SBAR (IN while) (S (NP-SBJ-18 (DT the) (ADJP (ADVP-TMP (RBR more) (RB slowly)) (VBG migrating)) (NN B1) (NN complex)) (VP (VBZ is) (VP (VBN composed) (NP (-NONE- *-18)) (PP (IN of) (NP-COOD (NP (NN p50)) (, ,) (NP (NN p55)) (, ,) (NP (NN p75)) (, ,) (CC and) (NP (NN p85))))))))))))) (. .))
(S (NP-SBJ (NP (JJ Site-directed) (NN mutagenesis)) (PP (IN of) (NP (NP (DT the) (JJ wild-type) (NN IL-2R) (NN alpha) (NN kappa) (NN B) (NN enhancer)) (PRN (-LRB- -LRB-) (NP (NN GGGGAATCTCCC)) (-RRB- -RRB-))))) (VP (VBZ has) (VP (VBN revealed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN binding)) (PP (IN of) (NP (NP-COOD (NP (NN p50)) (CC and) (NP (NN p55))) (PRN (-LRB- -LRB-) (NP (NN B2) (NN complex)) (-RRB- -RRB-))))) (VP (VBZ is) (ADJP-PRD (RB particularly) (JJ sensitive) (PP (TO to) (NP (NP (NN alteration)) (PP (IN of) (NP (NP (DT the) (JJ 5') (NN triplet)) (PP (IN of) (NP (NN deoxyguanosine) (NNS residues))))))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NP (NN formation)) (PP (IN of) (NP (DT the) (NN B1) (NN complex)))) (, ,) (VP (VBG reflecting) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP-COOD (NP (NN p75)) (CC and) (NP (NN p85)))))) (, ,)) (ADVP (RB critically)) (VP (VBZ depends) (PP (IN upon) (NP (NP (DT the) (RBR more) (JJ 3') (NNS sequences)) (PP (IN of) (NP (DT this) (NN enhancer) (NN element)))))) (. .))
(S (NP-SBJ-19 (NP (NN DNA) (NN binding)) (PP (IN by) (NP (NP (DT all) (CD four)) (PP (IN of) (NP (DT these) (JJ Rel-related) (NNS factors)))))) (VP (VBZ is) (VP (VBN blocked) (NP (-NONE- *-19)) (PP (IN by) (NP-LGS (NP (JJ selective) (JJ chemical) (NN modification)) (PP (IN of) (NP (NP-COOD (NP (NN lysine)) (CC and) (NP (NN arginine))) (NNS residues))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ-21 (NP (DT both)) (PP (IN of) (NP (DT these) (JJ basic) (NN amino) (NNS acids)))) (VP (VBP are) (VP (VBN required) (NP (-NONE- *-21)) (PP (IN for) (S (NP-SBJ (-NONE- *)) (VP (VBG binding) (PP (TO to) (NP (DT the) (NN kappa) (NN B) (NN element)))))))))))))) (. .))
(S (ADVP (RB Similarly)) (, ,) (NP-SBJ (NP (JJ covalent) (NN modification)) (PP (IN of) (NP (JJ free) (NN sulfhydryl) (NNS groups))) (PP (IN with) (NP-COOD (NP (NP (NN diamide)) (PRN (-LRB- -LRB-) (FRAG (ADJP (JJ reversible))) (-RRB- -RRB-))) (CC or) (NP (NP (NN N-ethylmaleimide)) (PRN (-LRB- -LRB-) (FRAG (ADJP (JJ irreversible))) (-RRB- -RRB-)))))) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJ complete) (NN loss)) (PP (IN of) (NP (NN DNA) (NN binding) (NN activity)))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-23 (NP (JJ mild) (NN oxidation)) (PP (IN with) (NP (NN glucose) (NN oxidase)))) (ADVP (RB selectively)) (VP (VBZ inhibits) (NP (NP-COOD (NP (NN p75)) (CC and) (NP (NN p85))) (NN binding)) (SBAR (IN while) (S (NP-SBJ (-NONE- *-23)) (VP (RB not) (VBG blocking) (NP (NP-COOD (NP (NN p50)) (CC and) (NP (NN p55))) (NNS interactions)))))) (. .))
(S (NP-SBJ (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (VBN reduced) (NN cysteine) (NNS thiols)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP (NP (DT this) (NN family)) (PP (IN of) (NP (JJ Rel-related) (NN transcription) (NNS factors))))))))))) (. .))
